On March 6, 2012, the United States District Court for the District of Maryland ruled in favor of arguments made by Hollingsworth LLP, that insurance coverage is an asset surviving...
After just over two hours of deliberation, an 11-person jury in the Western District of Kentucky (Bowling Green), returned a unanimous verdict in favor of Novartis Pharmaceuticals Corporation following a...
The U.S. District Court for the Eastern District of New York granted summary judgment in favor of firm client Sandoz Inc., along with APP Pharmaceuticals, Inc., Ben Venue Laboratories, Inc.,...
Judge P.K. Holmes of the U.S. District Court for the Western District of Arkansas granted Firm client Novartis Pharmaceuticals Corporation’s motion to dismiss in McDaniel v. Novartis Pharm. Corp., No....
A Magistrate Judge in the U.S. District Court for the Eastern District of North Carolina recommended that the motion of Novartis Pharmaceuticals Corporation (“NPC”) to apply New Jersey law to...
Judge Jessica Mayer granted the motion of defendant Novartis Pharmaceuticals Corporation (“NPC”) to apply New Jersey punitive damages law in a pharmaceutical products liability lawsuit filed in New Jersey state...
Judge William Duffey of the U.S. District Court for the Northern District of Georgia granted summary judgment in favor of Firm client Novartis Pharmaceuticals Corporation in a case alleging that...
The Mississippi Supreme Court reversed a $7 million jury verdict against Sherwin-Williams in a lead paint case, holding that the trial court erred in failing to exclude plaintiffs’ expert causation...
In Emerson v. Novartis Pharm. Corp., No. 09-6273, 2011 WL 3701835 (6th Cir. Aug. 23, 2011), the Sixth Circuit affirmed a grant of summary judgment based upon a statutory presumption...
In 2011, the Sixth Circuit affirmed summary judgment for Novartis in three cases, in which plaintiffs had no retained experts on the subject of specific causation, i.e., did Aredia and/or...
The U.S. Court of Appeals for the Second Circuit affirmed summary judgment in favor of Firm client General Electric International, Inc. (“GEII”), bringing to a close a wrongful death and...
The U.S. District Court for the Western District of North Carolina granted a motion filed by Firm client Novartis Pharmaceuticals Corporation (“NPC”) to preclude punitive damages law in this case...
In May 2011, Hollingsworth LLP obtained summary disposition for Firm client Sandoz Inc. in the case of Kerlinsky v. Sandoz, et al., which had been pending in the District of...
Novartis Pharmaceuticals Corp. (NPC), successfully opposed plaintiff’s attempt to re-designate her previously withdrawn oncology expert, Dr. James Vogel, a little more than a week before jury selection was scheduled to...
After two hours of deliberation, a New Brunswick, New Jersey jury returned a 7-2 verdict in favor of Novartis Pharmaceuticals Corporation in a ten-day trial involving Aredia and Zometa, bisphosphonate...
